Celgene Revenue 2006-2018 | CELG

Celgene annual/quarterly revenue history and growth rate from 2006 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Celgene revenue for the quarter ending December 31, 2018 was $4.037B, a 15.91% increase year-over-year.
  • Celgene revenue for the twelve months ending December 31, 2018 was $15.281B, a 17.52% increase year-over-year.
  • Celgene annual revenue for 2018 was $15.281B, a 17.52% increase from 2017.
  • Celgene annual revenue for 2017 was $13.003B, a 15.8% increase from 2016.
  • Celgene annual revenue for 2016 was $11.229B, a 21.32% increase from 2015.
Celgene Annual Revenue
(Millions of US $)
2018 $15,281
2017 $13,003
2016 $11,229
2015 $9,256
2014 $7,670
2013 $6,494
2012 $5,507
2011 $4,842
2010 $3,626
2009 $2,690
2008 $2,255
2007 $1,406
2006 $899
2005 $537
Celgene Quarterly Revenue
(Millions of US $)
Q4 2018 $4,037
Q3 2018 $3,892
Q2 2018 $3,814
Q1 2018 $3,538
Q4 2017 $3,483
Q3 2017 $3,287
Q2 2017 $3,271
Q1 2017 $2,962
Q4 2016 $2,980
Q3 2016 $2,983
Q2 2016 $2,754
Q1 2016 $2,512
Q4 2015 $2,563
Q3 2015 $2,334
Q2 2015 $2,278
Q1 2015 $2,081
Q4 2014 $2,086
Q3 2014 $1,982
Q2 2014 $1,873
Q1 2014 $1,730
Q4 2013 $1,756
Q3 2013 $1,674
Q2 2013 $1,599
Q1 2013 $1,465
Q4 2012 $1,447
Q3 2012 $1,419
Q2 2012 $1,367
Q1 2012 $1,273
Q4 2011 $1,284
Q3 2011 $1,250
Q2 2011 $1,183
Q1 2011 $1,125
Q4 2010 $1,072
Q3 2010 $910
Q2 2010 $853
Q1 2010 $791
Q4 2009 $761
Q3 2009 $695
Q2 2009 $629
Q1 2009 $605
Q4 2008 $628
Q3 2008 $592
Q2 2008 $571
Q1 2008 $463
Q4 2007 $415
Q3 2007 $350
Q2 2007 $348
Q1 2007 $293
Q4 2006 $275
Q3 2006 $245
Q2 2006 $197
Q1 2006 $182
Q4 2005 $149
Q3 2005 $130
Q2 2005 $146
Q1 2005 $112
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $66.417B $15.281B
Celgene Corporation is a global biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies for the treatment of cancer and immune-inflammatory related diseases. Their portfolio of commercial products include REVLIMID, VIDAZA, THALOMID, POMALYST/IMNOVID, ABRAXANE, OTEZLA, ISTODAX and IDHIFA. The drug candidates in their pipeline are at various stages of preclinical and clinical development. These candidates include their IMiDs compounds, which are a proprietary class of compounds that have certain immunomodulatory and other biologically important properties in addition to their leading oral anti-inflammatory agents and cellular therapies. They believe their commercial stage products and the depth of their product pipeline, provide the catalysts for future growth.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $115.829B 13.05
Gilead Sciences (GILD) United States $82.321B 10.48
Illumina (ILMN) United States $48.412B 57.60
Vertex Pharmaceuticals (VRTX) United States $45.952B 61.56
Biogen (BIIB) United States $44.991B 8.72
Regeneron Pharmaceuticals (REGN) United States $40.180B 18.66
Alexion Pharmaceuticals (ALXN) United States $30.602B 18.97
Incyte (INCY) United States $16.494B 153.96
BioMarin Pharmaceutical (BMRN) United States $15.788B 0.00
Seattle Genetics (SGEN) United States $12.345B 0.00
Exact Sciences (EXAS) United States $11.974B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.414B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.133B 52.39
QIAGEN (QGEN) Netherlands $8.959B 29.65
Sarepta Therapeutics (SRPT) United States $8.668B 0.00
Bluebird Bio (BLUE) United States $8.464B 0.00
Moderna (MRNA) United States $7.824B 0.00
BeiGene (BGNE) Cayman Islands $7.681B 0.00
Bio-Techne Corp (TECH) United States $7.375B 49.69
Exelixis (EXEL) United States $6.886B 15.98
Guardant Health (GH) United States $6.584B 0.00
Galapagos (GLPG) Belgium $5.979B 0.00
Amarin (AMRN) Ireland $5.938B 0.00
Alkermes (ALKS) Ireland $5.370B 0.00
Array BioPharma (ARRY) United States $5.119B 0.00
Horizon Pharma Public (HZNP) Ireland $4.727B 14.01
Ascendis Pharma (ASND) Denmark $4.688B 0.00
Spark Therapeutics (ONCE) United States $4.208B 0.00
ARGENX SE-ADR (ARGX) Netherlands $3.945B 0.00
China Biologic Products (CBPO) China $3.812B 23.62
ACADIA Pharmaceuticals (ACAD) United States $3.670B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.503B 0.00
Blueprint Medicines (BPMC) United States $3.444B 0.00
Immunomedics (IMMU) United States $3.331B 0.00
Global Blood Therapeutics (GBT) United States $3.285B 0.00
Allogene Therapeutics (ALLO) United States $3.191B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.107B 0.00
Amicus Therapeutics (FOLD) United States $3.051B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.741B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.723B 0.00
Emergent Biosolutions (EBS) United States $2.720B 22.62
Akcea Therapeutics (AKCA) United States $2.593B 0.00
Denali Therapeutics (DNLI) United States $2.552B 0.00
Ligand Pharmaceuticals (LGND) United States $2.550B 19.04
Insmed (INSM) United States $2.497B 0.00
Reata Pharmaceuticals (RETA) United States $2.457B 0.00
Repligen (RGEN) United States $2.430B 74.76
Myriad Genetics (MYGN) United States $2.418B 24.63
Halozyme Therapeutics (HALO) United States $2.415B 0.00
Genomic Health (GHDX) United States $2.406B 61.51
Arena Pharmaceuticals (ARNA) United States $2.357B 0.00
Acceleron Pharma (XLRN) United States $2.253B 0.00
Mirati Therapeutics (MRTX) United States $2.248B 0.00
Medicines (MDCO) United States $2.129B 0.00
UniQure (QURE) Netherlands $2.129B 0.00
AnaptysBio (ANAB) United States $2.088B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.043B 0.00
MyoKardia (MYOK) United States $2.007B 0.00
REGENXBIO (RGNX) United States $1.965B 20.41
NeoGenomics (NEO) United States $1.951B 158.69
Nabriva Therapeutics AG (NBRV) Ireland $1.882B 0.00
Audentes Therapeutics (BOLD) United States $1.750B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.736B 0.00
Alector (ALEC) United States $1.715B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.654B 0.00
Atara Biotherapeutics (ATRA) United States $1.647B 0.00
Allakos (ALLK) United States $1.594B 0.00
Rubius Therapeutics (RUBY) United States $1.501B 0.00
Myovant Sciences (MYOV) United Kingdom $1.411B 0.00
Innoviva (INVA) United States $1.393B 3.84
Lion Biotechnologies (IOVA) United States $1.392B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.392B 0.00
Editas Medicine (EDIT) United States $1.336B 0.00
Aimmune Therapeutics (AIMT) United States $1.336B 0.00
Cambrex (CBM) United States $1.324B 14.25
InflaRx (IFRX) Germany $1.313B 0.00
Puma Biotechnology (PBYI) United States $1.304B 0.00
Sangamo Therapeutics (SGMO) United States $1.226B 0.00
Apellis Pharmaceuticals (APLS) United States $1.209B 0.00
Epizyme (EPZM) United States $1.201B 0.00
Gossamer Bio (GOSS) United States $1.146B 0.00
Clovis Oncology (CLVS) United States $1.124B 0.00
Codexis (CDXS) United States $1.115B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.080B 0.00
Fate Therapeutics (FATE) United States $1.073B 0.00
Coherus BioSciences (CHRS) United States $1.046B 0.00
NGM BIOPHARMACT (NGM) United States $1.018B 0.00
Clementia Pharmaceuticals (CMTA) Canada $1.004B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.993B 0.00
Genfit SA (GNFT) France $0.946B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.934B 0.00
RA PHARMCTL INC (RARX) United States $0.925B 0.00
Eidos Therapeutics (EIDX) United States $0.921B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.917B 37.06
Rhythm Pharmaceuticals (RYTM) United States $0.911B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.903B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.898B 0.00
Retrophin (RTRX) United States $0.877B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.843B 0.00
WAVE Life Sciences (WVE) Singapore $0.837B 0.00
Cellectis (CLLS) France $0.832B 0.00
ANI Pharmaceuticals (ANIP) United States $0.813B 14.88
Vericel (VCEL) United States $0.811B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.807B 0.00
Twist Bioscience (TWST) United States $0.789B 0.00
Intellia Therapeutics (NTLA) United States $0.786B 0.00
Athenex (ATNX) United States $0.782B 0.00
Cara Therapeutics (CARA) United States $0.762B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.721B 0.00
Arvinas (ARVN) United States $0.717B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.716B 0.00
Intra-Cellular Therapies (ITCI) United States $0.698B 0.00
Principia Biopharma (PRNB) United States $0.695B 0.00
MeiraGTx Holdings (MGTX) United States $0.670B 0.00
G1 THERAPEUTICS (GTHX) United States $0.664B 0.00
Viking Therapeutics (VKTX) United States $0.658B 0.00
Osiris Therapeutics (OSIR) United States $0.656B 0.00
Precision BioSciences (DTIL) United States $0.650B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.626B 0.00
Revance Therapeutics (RVNC) United States $0.614B 0.00
Stemline Therapeutics (STML) United States $0.610B 0.00
ObsEva SA (OBSV) Switzerland $0.603B 0.00
Synthorx (THOR) United States $0.591B 0.00
Kura Oncology (KURA) United States $0.585B 0.00
Heska (HSKA) United States $0.578B 51.85
Zealand Pharma (ZEAL) Denmark $0.570B 6.35
Acorda Therapeutics (ACOR) United States $0.568B 7.36
Arcus Biosciences (RCUS) United States $0.545B 0.00
Mesoblast (MESO) Australia $0.541B 0.00
DBV Technologies (DBVT) France $0.537B 0.00
Magenta Therapeutics (MGTA) United States $0.532B 0.00
UROGEN PHARMA (URGN) United States $0.526B 0.00
Axsome Therapeutics (AXSM) United States $0.515B 0.00
Zymeworks (ZYME) Canada $0.509B 0.00
AVROBIO (AVRO) United States $0.498B 0.00
Sorrento Therapeutics (SRNE) United States $0.496B 0.00
CytomX Therapeutics (CTMX) United States $0.476B 0.00
PDL BioPharma (PDLI) United States $0.473B 10.54
ProQR Therapeutics (PRQR) Netherlands $0.468B 0.00
CYCLERION THERA (CYCN) United States $0.464B 0.00
Cytokineticsorporated (CYTK) United States $0.460B 0.00
Anika Therapeutics (ANIK) United States $0.457B 17.30
Five Prime Therapeutics (FPRX) United States $0.453B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.451B 0.00
Krystal Biotech (KRYS) United States $0.444B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.444B 0.00
Prothena (PRTA) Ireland $0.436B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.434B 0.00
Dynavax Technologies (DVAX) United States $0.430B 0.00
Gritstone Oncology (GRTS) United States $0.428B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.424B 0.00
MediciNova (MNOV) United States $0.421B 0.00
KALEIDO BIOSCI (KLDO) $0.420B 0.00
Scholar Rock Holding (SRRK) United States $0.414B 0.00
Albireo Pharma (ALBO) United States $0.397B 0.00
Replimune (REPL) United States $0.396B 0.00
Kezar Life Sciences (KZR) United States $0.391B 0.00
Abeona Therapeutics (ABEO) United States $0.391B 0.00
Inovio Pharmaceuticals (INO) United States $0.384B 0.00
Adverum Biotechnologies (ADVM) United States $0.375B 0.00
Merus (MRUS) Netherlands $0.375B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
STEALTH BIOTHER (MITO) United States $0.370B 0.00
Senesco Technologies (ELOX) United States $0.366B 0.00
PHASEBIO PHARMA (PHAS) United States $0.355B 0.00
Agenus (AGEN) United States $0.352B 0.00
BeyondSpring (BYSI) United States $0.345B 0.00
BioDelivery Sciences (BDSI) United States $0.344B 0.00
Kindred Biosciences (KIN) United States $0.344B 0.00
UNITY Biotechnology (UBX) $0.344B 0.00
AC Immune SA (ACIU) Switzerland $0.334B 0.00
Geron (GERN) United States $0.334B 0.00
Constellation Pharmaceuticals (CNST) United States $0.323B 0.00
Kadmon Holdings (KDMN) United States $0.320B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.319B 0.00
XBiotech (XBIT) United States $0.318B 0.00
Solid Biosciences (SLDB) United States $0.316B 0.00
Cellular Biomedicine (CBMG) United States $0.309B 0.00
MannKind (MNKD) United States $0.304B 0.00
LogicBio Therapeutics (LOGC) United States $0.296B 0.00
Aduro Biotech (ADRO) United States $0.295B 0.00
Seres Therapeutics (MCRB) United States $0.286B 0.00
Kala Pharmaceuticals (KALA) United States $0.268B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.266B 0.00
Urovant Sciences (UROV) United States $0.265B 0.00
Enochian BioSciences (ENOB) United States $0.261B 0.00
Sutro Biopharma (STRO) United States $0.260B 0.00
Evelo Biosciences (EVLO) United States $0.260B 0.00
Kodiak Sciences (KOD) United States $0.259B 0.00
Novavax (NVAX) United States $0.257B 0.00
ResTORbio (TORC) United States $0.256B 0.00
Strongbridge Biopharma (SBBP) United States $0.249B 0.00
Kamada (KMDA) Israel $0.247B 11.15
Protagonist Therapeutics (PTGX) United States $0.246B 0.00
Syros Pharmaceuticals (SYRS) United States $0.241B 0.00
Avid Bioservices (CDMO) United States $0.239B 0.00
Celcuity (CELC) United States $0.235B 0.00
Palatin Technologies (PTN) United States $0.231B 114.00
Xenon Pharmaceuticals (XENE) Canada $0.228B 0.00
ADMA Biologics Inc (ADMA) United States $0.225B 0.00
Cerecor (CERC) United States $0.221B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.215B 0.00
ChromaDex (CDXC) United States $0.213B 0.00
Intec Pharma (NTEC) Israel $0.213B 0.00
Spero Therapeutics (SPRO) United States $0.212B 0.00
Mersana Therapeutics (MRSN) United States $0.211B 0.00
Synlogic (SYBX) United States $0.211B 0.00
OvaScience (MLND) United States $0.210B 0.00
Celyad SA (CYAD) Belgium $0.209B 0.00
TOCAGEN INC (TOCA) United States $0.208B 0.00
Athersys (ATHX) United States $0.207B 0.00
OSMOTICA PHARM (OSMT) United States $0.204B 0.00
CorMedix Inc (CRMD) United States $0.203B 0.00
VBI Vaccines (VBIV) United States $0.203B 0.00
Arbutus Biopharma (ABUS) Canada $0.201B 0.00
Gamida Cell (GMDA) Israel $0.200B 0.00
Cel-Sci (CVM) United States $0.197B 0.00
Axovant Sciences (AXGT) United Kingdom $0.193B 0.00
BioTime (BTX) United States $0.193B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.192B 0.00
Compugen (CGEN) Israel $0.189B 0.00
Cue Biopharma (CUE) United States $0.184B 0.00
Pfenex (PFNX) United States $0.178B 0.00
Verastem (VSTM) United States $0.175B 0.00
Menlo Therapeutics (MNLO) United States $0.172B 0.00
Enzo Biochem (ENZ) United States $0.169B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.157B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.156B 0.00
BioXcel Therapeutics (BTAI) United States $0.156B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.152B 0.00
Liquidia Technologies (LQDA) United States $0.151B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.148B 0.00
Chiasma (CHMA) United States $0.143B 0.00
Trevena (TRVN) United States $0.141B 0.00
Allena Pharmaceuticals (ALNA) United States $0.139B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.139B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.136B 0.00
Anavex Life Sciences (AVXL) United States $0.135B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.133B 0.00
Eton Pharmaceuticals (ETON) United States $0.131B 0.00
Aptinyx (APTX) United States $0.129B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.128B 0.00
VolitionRX (VNRX) Singapore $0.126B 0.00
Organovo Holdings (ONVO) United States $0.119B 0.00
XOMA (XOMA) United States $0.115B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.114B 0.00
Cohbar (CWBR) United States $0.114B 0.00
Unum Therapeutics (UMRX) United States $0.113B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.113B 0.00
Selecta Biosciences (SELB) United States $0.112B 0.00
Neothetics (EVFM) United States $0.111B 0.00
Provention Bio (PRVB) United States $0.108B 0.00
Catalyst Biosciences (CBIO) United States $0.106B 0.00
SESEN BIO, INC (SESN) United States $0.105B 0.00
NantKwest (NK) United States $0.104B 0.00
Checkpoint Therapeutics (CKPT) United States $0.102B 0.00
INMUNE BIO INC (INMB) United States $0.102B 0.00
Equillium (EQ) United States $0.098B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.096B 0.00
Signal Genetics (MGEN) United States $0.090B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.088B 0.00
Applied Genetic Technologies (AGTC) United States $0.086B 0.00
Cocrystal Pharma (COCP) United States $0.085B 90.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.084B 0.00
Alcobra (ARCT) United States $0.084B 0.00
Fortress Biotech (FBIO) United States $0.081B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.080B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.080B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.080B 0.00
Mustang Bio (MBIO) United States $0.080B 0.00
Eyenovia (EYEN) United States $0.077B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.077B 0.00
Orgenesis (ORGS) United States $0.076B 0.00
Aptose Biosciences (APTO) Canada $0.074B 0.00
Alimera Sciences (ALIM) United States $0.072B 0.00
Idera Pharmaceuticals (IDRA) United States $0.072B 0.00
ARAVIVE, INC (ARAV) United States $0.072B 0.00
Pluristem Therapeutics (PSTI) Israel $0.072B 0.00
AEterna Zentaris (AEZS) United States $0.072B 17.40
Cidara Therapeutics (CDTX) United States $0.071B 0.00
OVID THERAPEUTC (OVID) United States $0.071B 0.00
Proteostasis Therapeutics (PTI) United States $0.065B 0.00
Protalix BioTherapeutics (PLX) Israel $0.065B 0.00
Curis (CRIS) United States $0.064B 0.00
Vaccinex (VCNX) United States $0.064B 0.00
Apricus Biosciences (SEEL) United States $0.063B 0.00
NewLink Genetics (NLNK) United States $0.063B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.063B 0.00
VTv Therapeutics (VTVT) United States $0.061B 0.00
Evogene (EVGN) Israel $0.060B 0.00
Ophthotech (OPHT) United States $0.058B 0.00
Prima BioMed (IMMP) Australia $0.053B 0.00
ScPharmaceuticals (SCPH) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
Celldex Therapeutics (CLDX) United States $0.050B 0.00
ANCHIANO THERAP (ANCN) Israel $0.049B 0.00
Entera Bio (ENTX) Israel $0.049B 0.00
VistaGen Therapeutics (VTGN) United States $0.049B 0.00
AquaBounty Technologies (AQB) United States $0.049B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.049B 0.00
AZURRX BIOPHARM (AZRX) United States $0.047B 0.00
Clearside Biomedical (CLSD) United States $0.046B 0.00
Bellerophon Therapeutics (BLPH) United States $0.046B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.046B 0.00
HOTH THERAPEUTC (HOTH) United States $0.046B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.044B 0.00
Celsion (CLSN) United States $0.043B 0.00
DiaMedica Therapeutics (DMAC) United States $0.043B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.041B 0.00
Bionano Genomics (BNGO) United States $0.041B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.039B 0.00
Zosano Pharma (ZSAN) United States $0.039B 0.00
OncoSec Medical (ONCS) United States $0.039B 0.00
Leap Therapeutics (LPTX) United States $0.037B 0.00
VIVUS (VVUS) United States $0.036B 0.00
Arsanis (XFOR) United States $0.036B 0.00
Aptevo Therapeutics (APVO) United States $0.035B 0.00
Motif Bio Plc (MTFB) United States $0.035B 0.00
Oncolytics Biotech (ONCY) Canada $0.033B 0.00
Caladrius Biosciences (CLBS) United States $0.032B 0.00
Sophiris Bio (SPHS) United States $0.031B 0.00
Adial Pharmaceuticals (ADIL) United States $0.030B 0.00
GENPREX INC (GNPX) United States $0.028B 0.00
GTx (GTXI) United States $0.027B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.027B 0.00
Moleculin Biotech (MBRX) United States $0.027B 0.00
Novelion Therapeutics (NVLN) Canada $0.026B 0.00
Aytu Bioscience (AYTU) United States $0.026B 0.00
Aileron Therapeutics (ALRN) United States $0.026B 0.00
Vical (VICL) United States $0.025B 0.00
Oragenics (OGEN) United States $0.025B 0.00
Galena Biopharma (SLS) United States $0.024B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Fibrocell Science Inc (FCSC) United States $0.022B 0.00
TRACON Pharmaceuticals (TCON) United States $0.022B 0.00
IMMURON LTD (IMRN) Australia $0.021B 0.00
ATyr Pharma (LIFE) United States $0.020B 0.00
Benitec Biopharma (BNTC) Australia $0.020B 0.00
CytRx (CYTR) United States $0.019B 0.00
Advaxis (ADXS) United States $0.019B 0.00
Gemphire Therapeutics (GEMP) United States $0.019B 0.00
Histogenics (HSGX) United States $0.018B 0.00
Oncobiologics (OTLK) United States $0.018B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
Novogen (KZIA) Australia $0.017B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
BioPharmX (BPMX) United States $0.016B 0.00
IBio (IBIO) United States $0.015B 0.00
TrovaGene (TROV) United States $0.014B 0.00
Alliqua BioMedical (ALQA) United States $0.014B 0.00
Soligenix (SNGX) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Genetic Technologies (GENE) Australia $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
Dare Bioscience (DARE) United States $0.012B 0.00
Therapix Biosciences (TRPX) Israel $0.012B 5.91
AmpliPhi Biosciences (APHB) United States $0.012B 0.00
RestorGenex (DFFN) United States $0.011B 0.00
Flex Pharma (FLKS) United States $0.011B 0.00
Tenax Therapeutics (TENX) United States $0.010B 0.00
Proteon Therapeutics (PRTO) United States $0.010B 0.00
Edge Therapeutics (PDSB) United States $0.010B 0.00
Synthetic Biologics (SYN) United States $0.010B 0.00
Hemispherx BioPharma (HEB) United States $0.009B 0.00
Pulmatrix (PULM) United States $0.009B 0.00
Neuralstem (CUR) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cellect Biotechnology (APOP) Israel $0.005B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.005B 0.00